K. Celegen Et Al. , "LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME," PEDIATRIC NEPHROLOGY , vol.32, no.9, pp.1769-1770, 2017
Celegen, K. Et Al. 2017. LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME. PEDIATRIC NEPHROLOGY , vol.32, no.9 , 1769-1770.
Celegen, K., GÜLHAN, B., Inozu, M., TAŞ, N., ÖZALTIN, F., DÜZOVA, A., ... TOPALOĞLU, R.(2017). LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME. PEDIATRIC NEPHROLOGY , vol.32, no.9, 1769-1770.
Celegen, Kubra Et Al. "LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME," PEDIATRIC NEPHROLOGY , vol.32, no.9, 1769-1770, 2017
Celegen, Kubra Et Al. "LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME." PEDIATRIC NEPHROLOGY , vol.32, no.9, pp.1769-1770, 2017
Celegen, K. Et Al. (2017) . "LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME." PEDIATRIC NEPHROLOGY , vol.32, no.9, pp.1769-1770.
@article{article, author={Kubra Celegen Et Al. }, title={LONG TERM RESULTS OF RITUXIMAB IN A TERTIARY REFERRAL CENTER FOR DIFFICULT-TO-TREAT NEPHROTIC SYNDROME}, journal={PEDIATRIC NEPHROLOGY}, year=2017, pages={1769-1770} }